Stämm Biotech, founded in 2014 and based in San Francisco, California, specializes in innovative biomanufacturing solutions for the life sciences sector. The company has developed a novel bioproduction system that integrates microfluidics, electroporation, and robotics to address the challenges of scaling in the biotech industry. Stämm's flagship product, the Bioprocessor, is an all-in-one, plug-and-play desktop unit that significantly enhances productivity, being at least 70 times more efficient than conventional bioreactors. Additionally, Stämm offers a suite of products including an automated continuous batch system for microbial growth, tools for tracking biological variations, and systems for monitoring microorganisms to convert data into actionable insights. This technological advancement positions Stämm to unlock a substantial market opportunity in biomanufacturing over the next decade.
Tomorrow Foods develops and produces plant based ingredients and aditives for the food industry. It products are used in sport nutrition, meat extenders, pasta, dressing, soups, sauces, snacks, cereals, functional beverages, dairy substitutes, and bakery. The company is based in Pergamino, Argentina.
Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.
Developer of a biotech platform designed to unlock the product innovation growth of the plant-based industry. The company uses fermentation and software to enhance the flavor, texture, and nutrition of plant substrates, enabling consumers a healthier, ecological, and sustainable way of eating.
Beeflow S.A. is a company that specializes in professional pollination services, focusing on the enhancement of bee health and efficiency. Founded in 2016 and headquartered in Buenos Aires, Argentina, Beeflow employs scientific techniques and organic compounds to improve the immune systems of bees, enabling them to effectively pollinate specific crops. The company has demonstrated significant success in increasing crop yields, with reported improvements ranging from 20% to 90% in various fruits such as blueberries, almonds, raspberries, and kiwifruit. Since its inception, Beeflow has expanded its operations to the United States and continues to grow its presence, particularly in Ventura County, California. The company's efforts aim to address the challenges of declining bee populations while supporting agricultural productivity.
Cryosmetics is a company dedicated to advancing the field of cosmetics by developing natural skincare products that enhance the diversity of the skin microbiome. The company combines technology, science, and biology to create innovative skincare solutions. Its products are formulated using natural raw materials, ensuring they are free from preservatives and synthetic chemicals. This approach not only promotes skin health but also aims to improve the overall well-being of customers. By focusing on the crucial role of microbiomes in skincare, Cryosmetics is positioning itself as a forward-thinking player in the cosmetics industry.
OncoPrecision
Pre Seed Round in 2020
We're developing personalized assays to determine the most suitable medication for cancer therapy at the patient level. Through our proprietary Drug Activity Ranking, oncologists will be able to make data-driven decisions regarding cancer therapy selection based on patient-derived samples. Our goal is to democratize access to precision oncology to improve patients' lives.
ArgenTAG specializes in developing synthetic DNA barcoding technology aimed at enhancing the capabilities of long-read sequencing applications in genomics. By addressing the limitations associated with reduced multiplexing capacity and sequencing throughput, ArgenTAG enables the simultaneous analysis of thousands of samples. The company integrates advanced micro-fabrication techniques with next-generation DNA sequencing and molecular biology, leveraging reengineered error correction technologies initially derived from digital communications. This innovative approach facilitates the decentralization of genome sequencing, allowing medical professionals to effectively analyze antibodies and perform single-cell sequencing, thus advancing the field of personalized medicine.
Developer of nanotechnology-based device designed to diagnose and detect renal biomarkers. The company's device is used to measure the concentration of urea, creatinine, and potassium from a single drop of blood which is tracked by the application in real-time, enabling scientists with real-time and portable health monitoring.
CASPR Biotech is a San Francisco-based company established in 2018 that specializes in developing a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company focuses on creating portable diagnostic kits that enable the detection of specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. By offering a simple, fast, and affordable solution, CASPR Biotech aims to assist healthcare providers in delivering efficient diagnostics within clinical and hospital settings.
Fecundis operates in the reproductive biology field. It develops solutions to improve sperm competence and increase rates of assisted reproductive technologies. The company is based in Rosario, Argentina.
Michroma Corporation is a biotechnology company based in San Francisco, California, founded in 2019. The company specializes in producing natural thermostable colorants derived from filamentous fungi, aiming to replace synthetic and non-sustainable colorants commonly used in food and cosmetics. By leveraging a fermentation process and utilizing colorful fungal strains, Michroma provides a diverse array of pH-stable and heat-stable natural pigments. This innovative approach not only supports sustainability but also caters to the growing demand for vegetarian and environmentally friendly alternatives in the food industry.
Hiamet S.A. is a biotechnology company based in Santa Fe, Argentina, specializing in the development and manufacturing of additives for biogas production. The company provides comprehensive services including process design, development, analysis, and scale-up of biotechnological applications. Hiamet focuses on addressing specific challenges related to bioenergy and environmental impact by creating solutions that facilitate the conversion of organic waste into energy.
Syocin Biotech is a company based in Rosario, Argentina, dedicated to developing a synthetic biology platform aimed at redesigning natural biomolecules. This innovative platform focuses on creating precision bactericidal proteins that specifically target plant bacterial pathogens, which pose significant risks to global food availability. By leveraging this technology, Syocin Biotech provides sustainable bioproducts for agriculture, enabling efficient and effective solutions to combat crop pathogens.
Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.
Einsted is an biotechnology company based in Argentina, developing a BioElectroProcessor for bioindustrial processes optimization. Our goal is to generate NanoPulsed Reactions (NPR) for the Food, Pharma and Cosmetic industries.
Tomorrow Foods develops and produces plant based ingredients and aditives for the food industry. It products are used in sport nutrition, meat extenders, pasta, dressing, soups, sauces, snacks, cereals, functional beverages, dairy substitutes, and bakery. The company is based in Pergamino, Argentina.
CASPR Biotech is a San Francisco-based company established in 2018 that specializes in developing a CRISPR-based platform for diagnosing antimicrobial resistances (AMR) and infectious diseases. The company focuses on creating portable diagnostic kits that enable the detection of specific DNA and RNA sequences, as well as signature amino acid sequences associated with infectious diseases and genetic mutations. By offering a simple, fast, and affordable solution, CASPR Biotech aims to assist healthcare providers in delivering efficient diagnostics within clinical and hospital settings.
Zev Biotech is a biotechnology research company based in Argentina that focuses on the study of DNA for clinical diagnostic applications. The company aims to provide accessible molecular biology diagnostics by employing proprietary technologies that include reagents, equipment, and software based on microarray technology. This innovative approach enables healthcare professionals to diagnose genetic and infectious diseases with greater accuracy than traditional clinical methods. Through its advancements, Zev Biotech seeks to improve diagnostic capabilities and enhance patient care.
MZP Tecnología is a company based in San Carlos de Bariloche, Argentina, focused on developing innovative diagnostic medical devices that utilize micro technology and embedded systems. The company's primary product is a coagulation diagnostic device designed to analyze blood quickly and efficiently. It operates using a disposable micro-machined chip capable of analyzing a single drop of blood within minutes. The device measures blood viscosity, allowing medical professionals to conduct early-stage screenings for cardiovascular-related diseases, blood-clotting issues, and hyperviscosity-related conditions. Additionally, MZP Tecnología offers a microfluidics platform that includes microviscometers and an embedded system for data acquisition, processing, and remote access, enhancing the capabilities of fluid analysis in a portable format.
Feedvax is an Argentine company founded in 2018 that specializes in developing oral vaccines for farmed fish. The company creates environmentally safe and effective vaccines that can be incorporated into feed, providing an innovative solution to protect fish from diseases while reducing the reliance on antibiotics in aquaculture. Feedvax's initial product targets Streptococcus infections in tilapia, one of the most commonly farmed fish species globally. By offering a cost-effective and user-friendly vaccination method, Feedvax aims to enhance the health of farmed fish, minimize stress on the animals, and contribute to more sustainable aquaculture practices.
Cell Farm is a pioneering clean meat startup based in Latin America that focuses on producing cultured meat from animal stem cells. By developing and standardizing a biotechnology process, the company aims to eliminate the need for traditional animal farming, thereby promoting sustainability within the food system. Cell Farm's innovative approach allows for the cultivation of meat without sacrificing living beings, addressing concerns related to animal welfare, environmental impact, and consumer health. Through its efforts, Cell Farm positions itself as a significant contributor to a more ethical and sustainable food future.
Algaebio+ is an Argentine company focused on the production of natural astaxanthin, an antioxidant renowned for its immunoregulatory, anti-inflammatory, and photoprotective properties. The company's product is designed to support human and animal health, offering benefits for conditions related to joints, muscles, vision, and heart health. Algaebio+ serves various industries, including pharmaceuticals, nutraceuticals, and cosmetics, aiming to provide alternatives to artificial pigments and enhance treatment options for chronic diseases. Through its innovative approach, the company contributes to the development of compounds that promote wellness and preventive care.
Alytix Biotech specializes in bacteriophage technology aimed at controlling and treating bacterial infections in both human and animal health. The company develops alternatives to traditional antibiotics, offering solutions that include screening, identification, characterization, formulation, and validation of antibiotic resistance. By providing pharmaceutical companies with innovative methods to combat bacterial infections, Alytix aims to address the growing challenge of antibiotic resistance. Based in Santa Fe, Argentina, the company is positioned to make significant contributions to the field of infection control and treatment.
Bitgenia is an Argentine bioinformatics company established in 2015, based in Ciudad Autonoma de Buenos Aires. It specializes in genomic analysis by offering a comprehensive platform designed to process and interpret next-generation sequencing (NGS) data. The company’s proprietary B-Platform facilitates the analysis and storage of data from various genomic studies, including gene panels, exomes, and whole genomes. Additionally, Bitgenia provides customized software solutions tailored for NGS data management, along with training and support services. By centralizing and integrating genomic information, Bitgenia aims to enhance diagnostic precision, treatment design, and preventive health measures, ultimately contributing to improved healthcare outcomes.
Aplife Biotech is an Argentinean biotech Start-up currently in the process of developing cutting-edge technology for the high-throughput discovery of novel aptamers to be used in biosensors.
Beeflow S.A. is a company that specializes in professional pollination services, focusing on the enhancement of bee health and efficiency. Founded in 2016 and headquartered in Buenos Aires, Argentina, Beeflow employs scientific techniques and organic compounds to improve the immune systems of bees, enabling them to effectively pollinate specific crops. The company has demonstrated significant success in increasing crop yields, with reported improvements ranging from 20% to 90% in various fruits such as blueberries, almonds, raspberries, and kiwifruit. Since its inception, Beeflow has expanded its operations to the United States and continues to grow its presence, particularly in Ventura County, California. The company's efforts aim to address the challenges of declining bee populations while supporting agricultural productivity.
Stämm Biotech, founded in 2014 and based in San Francisco, California, specializes in innovative biomanufacturing solutions for the life sciences sector. The company has developed a novel bioproduction system that integrates microfluidics, electroporation, and robotics to address the challenges of scaling in the biotech industry. Stämm's flagship product, the Bioprocessor, is an all-in-one, plug-and-play desktop unit that significantly enhances productivity, being at least 70 times more efficient than conventional bioreactors. Additionally, Stämm offers a suite of products including an automated continuous batch system for microbial growth, tools for tracking biological variations, and systems for monitoring microorganisms to convert data into actionable insights. This technological advancement positions Stämm to unlock a substantial market opportunity in biomanufacturing over the next decade.